QIF-T0073
criticalEar-canal neural eavesdropping via modified consumer earbud (supply chain in-ear EEG)
Tier 4 — Demonstrated (Case Study / Observational)
Legacy status: EMERGING
The ear canal is 5-10mm from temporal cortex through the canal wall and temporal bone — close enough for a conductive ear tip with a high-gain biopotential amplifier to capture cortical EEG. Commercial in-ear EEG has been proven viable (Idun Guardian, cEEGrid, Cognionics). In a supply chain attack, a consumer earbud is modified to include: (1) a conductive silicone ear tip that makes galvanic contact with ear canal skin, (2) a sub-$5 biopotential amplifier (e.g., ADS1299 or TI ADS129x family) hidden in the earbud housing, and (3) modified firmware that multiplexes captured EEG data alongside normal audio. The captured signals include auditory evoked potentials (AEP), P300 attention markers, N400 semantic processing indicators, and alpha/theta power reflecting cognitive state. Generic earbuds lacking proprietary authentication (unlike Apple AirPods with W1/H1 chip) are the attack surface. The attacker gets continuous neural telemetry from a device the target wears voluntarily for hours daily. This is the bridge technique between QIF-T0072 (acoustic eavesdropping) and QIF-T0074 (cognitive inference): it turns a consumer audio device into a covert neural recording platform.
Technique Details
- Tactic
- QIF-S.RP
- Status
- EMERGING
- Bands
- S1, I0, N1, N2, N3
✚ Therapeutic Application
Conductive ear tip and embedded biopotential amplifier in consumer earbud captures in-ear EEG from temporal cortex via ear canal proximity
Clinical Analog
In-ear EEG for seizure detection, sleep staging, cognitive monitoring
Treats
- epilepsy monitoring (continuous ambulatory EEG)
- sleep disorder diagnosis
- ADHD attention monitoring
- anesthesia depth monitoring
Neural Impact
5 of 7 neural bands affected
Drag to rotate. Click a region to learn more.
Click or hover over a glowing region to see the attack techniques targeting it and their severity.
DSM-5-TR Diagnostic Mappings
Diagnostic category references for threat modeling, not diagnostic claims.
Pathway: N3 (cerebellar cortex/deep cerebellar nuclei) → motor coordination; N2 (medulla/pons) → vital functions
Following Poldrack (2006), brain region disruption does not uniquely predict psychiatric outcomes.
Scoring
NISS:1.1/BI:N/CR:L/CD:L/CV:I/RV:F/NP:N CVSS:4.0/AV:P/AC:L/AT:P/PR:N/UI:N/VC:H/VI:N/VA:N/SC:H/SI:N/SA:N Governance
Neurorights at Risk
This technique threatens 3 of the 4 proposed neurorights (Ienca & Andorno, 2017).
FDORA §3305 Compliance
- ! CVSS cannot express neural-specific impacts
- ! No FDA pathway for consumer sensor exploitation
Population Vulnerability
CRB vulnerability adjustment (γ=0.30) accounts for age, diagnosis severity, consent capacity, and device dependency.
| Population | NISS Base | Adjusted | Severity | Delta |
|---|---|---|---|---|
| Adult (Default) | 2.7 | 2.7 | Low | - |
| Child (10yr) + ADHD | 2.7 | 3.2 | Low | +0.48 |
| Adult with ALS | 2.7 | 3.1 | Low | +0.44 |
Validation Status
Theoretical / Not yet validated. This technique has not been independently tested. See the validation dashboard for what has been tested.